Skip to main content
. 2025 Jul 2;5(4):531–552. doi: 10.1021/acsbiomedchemau.5c00103

2. Antifungal Drug Classes Commonly Used for Treating Fungal Infections, Including Details of Their Targets, Mechanisms of Action, and Most Frequently Applied Representatives.

drug class representative agents target mechanism of action
polyenes amphotericin B, natamycin, nystatin cell membrane (direct) binds to ergosterol, forming pores in the fungal cell membrane, which leads to cell lysis
azoles imidazoles: clotrimazole, ketoconazole, luliconazole cell membrane (indirect) inhibits ergosterol biosynthesis by blocking lanosterol-14α-demethylase, compromising membrane structure and integrity
triazoles: efinaconazole, fluconazole, isavuconazole, itraconazole, posaconazole, voriconazole
allylamines butenafine, naftifine, terbinafine cell membrane (indirect) inhibits ergosterol biosynthesis by blocking the enzyme squalene epoxidase, damaging membrane formation and generating toxic squalene byproducts
echinocandins anidulafungin, caspofungin, micafungin cell wall (indirect) inhibits 1,3-β-d-glucan synthesis by targeting 1,3-β-glucan synthase, compromising fungal cell wall formation
others flucytosine nucleic acid synthesis (indirect) interferes with DNA and RNA synthesis via its metabolic products
griseofulvin cell division (direct) binds to tubulin, disrupting microtubule function and inhibiting fungal cell division
ciclopirox enzyme cofactors (direct) chelates polyvalent metal cations, inhibiting the function of enzymes vital for fungal cellular activities
amorolfine cell membrane (indirect) inhibits ergosterol biosynthesis by targeting Δ14-sterol reductase and Δ7–Δ8-cholestenol isomerase, impairing membrane formation